| 中文名 | 1H-1-乙基坎地沙坦西来替昔酯 |
|---|---|
| 英文名 | 1-cyclohexyloxycarbonyloxyethyl 2-ethoxy-3-[[4-[2-(1-ethyltetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate |
| 中文别名 |
1H-N1-乙基坎地沙坦酯
坎地沙坦 西里西替林 杂质E 坎地沙坦酯杂质5(坎地沙坦酯杂质E) 坎地沙坦酯杂质E 坎地沙坦西酯杂质E CANDESTAN CILEXETIL 杂质 E 坎地沙坦酯杂质05 坎地沙坦酯杂质E/杂质V 坎地沙坦环丙基1位氮乙基杂质 坎地沙坦杂质 2 1-[[(环己氧基)羰基]氧基]乙氧基2-乙氧基-1-[[2'-(1-乙基-1H-四唑-5-基)[1,1'-联苯]-4-基]甲基]-1H-苯并咪唑-7-羧酸盐 |
| 英文别名 |
1H-1-Ethyl Candestan Cilexetil
Candestan Imp E Candestan Cilexetil Impurity E (Candestan Cilexetil N1-Ethyl Analog) Candestan Impurity-E 1-N-ethyl CNS Candesartan Cilexetil Impurity 5 1H-1,2,4-Triazole,1-ethyl Candestan Cilexetil impurity E Candestan Impurity 2 N-ethyl-1,2,4-triazole Candestan Cilexetil Impurity EQ: What is Candestan Cilexetil Impurity E Q: What is the CAS Number of Candestan Cilexetil Impurity E Q: What is the storage condition of Candestan Cilexetil Impurity E Q: What e the applications of Candestan Cilexetil Impurity E 1-[[(Cyclohexyloxy)carbonyl]oxy]ethyl 2-ethoxy-1-[[2′-(1-ethyl-1H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-cboxylate 1H-Benzimidazole-7-cboxylic acid, 2-ethoxy-1-[[2'-(1-ethyl-1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester Candestan Cilexetil Impurity 5(Candestan Cilexetil Impurity E) 1-(((Cyclohexyloxy)carbonyl)oxy)ethyl 2-ethoxy-1-((2'- (1-ethyl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)- 1H-benzo[d]imidazole-7-cboxylate 2-Ethoxy-1-[[2'-(1-ethyl-1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]- 1H-benzimidazole-7-cboxylic acid 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester (1RS)-1-[[(cyclohexyloxy)carbonyl]oxy]ethyl 2-ethoxy-1-[[2'-(1- ethyl-1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7- cboxylate Candestan Cilexetil,1H1ethyl Candestan Cilexetil,Inhibitor,1H 1 ethyl Candestan Cilexetil,inhibit 1-N-ethyl 1,2,4-triazole 2-Ethoxy-1-[[2'-(1-ethyl-1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]Methyl] (1RS)-1-[[(Cyclohexyloxy)carbonyl]-oxy]ethyl 2-Ethoxy-1-[[2'-(1-ethyl-1H-tetrazol-5-yl)biphenyl-4-yl 1-cyclohexyloxycbonyloxyethyl 2-ethoxy-3-[[4-[2-(1-ethyltetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-cboxylate Candestan Cilexetil Imp. E : (1RS)-1-[[(cyclohexyloxy)carbonyl]oxy]ethyl 2-ethoxy- 1-[[2'-(1-ethyl-1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-cboxylate Candestan Cilexetil Impurity 5 Impurity E) |
| 分子式 | C35H38N6O6 |
|---|---|
| 分子量 | 638.71300 |
| 精确质量 | 638.28500 |
| PSA | 132.48000 |
| LogP | 6.81240 |
| 储存条件 | -20°C,密闭,干燥 |
|
~%
914613-35-7 |
| 文献:Havllcek, Jaroslav; Mandelova, Zuzana; Weisemann, Ruediger; Strelec, Ivo; Placek, Lukas; Radl, Stanislav Collection of Czechoslovak Chemical Communications, 2009 , vol. 74, # 2 p. 347 - 362 |
|
~%
914613-35-7 |
| 文献:TEVA PHARMACEUTICAL INDUSTRIES LTD.; TEVA PHARMACEUTICALS USA, INC. Patent: WO2006/122254 A2, 2006 ; Location in patent: Page/Page column 12; 13 ; |
| 上游产品 2 | |
|---|---|
| 下游产品 1 | |